Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. administers 268.4 million doses of COVID-19 vaccines - CDC

Published 05/14/2021, 02:43 PM
Updated 05/14/2021, 02:46 PM
© Reuters. Silas Tropea-Lester, 13, receives a coronavirus disease (COVID-19) vaccination at a vaccine clinic for newly eligible 12 to 15-year-olds at the Annenberg Foundation in Los Angeles, California, U.S., May 13, 2021. REUTERS/Lucy Nicholson

(Reuters) - The United States has administered 268,438,666 doses of COVID-19 vaccines in the country as of Friday morning and distributed 341,865,945 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 266,596,486 vaccine doses the CDC said had gone into arms by Thursday out of 339,165,445 doses delivered.

© Reuters. Silas Tropea-Lester, 13, receives a coronavirus disease (COVID-19) vaccination at a vaccine clinic for newly eligible 12 to 15-year-olds at the Annenberg Foundation in Los Angeles, California, U.S., May 13, 2021. REUTERS/Lucy Nicholson

The agency said 155,251,852 people had received at least one dose, while 120,258,637 people are fully vaccinated.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Friday.

Latest comments

Bill Gates said on CNBC he makes 20 to 1 profit from vaccine industry for every dollar.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.